OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$12.50 USD
-0.12 (-0.95%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $12.48 -0.02 (-0.16%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2025
Time: AMC |
6/2025 | $0.03 | 0.00% |
Earnings Summary
For their last quarter, OptimizeRx (OPRX) reported earnings of $0.08 per share, beating the Zacks Consensus Estimate of $-0.11 per share. This reflects a positive earnings surprise of 172.73%. Look out for OPRX's next earnings release on August 07, 2025. For the next earning release, we expect the company to report earnings of $0.03 per share, reflecting a year-over-year increase of 50%.
Earnings History
Price & Consensus
Zacks News for OPRX
Bull Of The Day: OptimizeRX (OPRX)
OPRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
Blackbaud (BLKB) Q2 Earnings and Revenues Surpass Estimates
Take the Zacks Approach to Beat the Markets: AngloGold Ashanti, Caterpillar & Hershey in Focus
OPRX FAQs
OptimizeRx Corp. (OPRX) has announced they will report their next quarter earnings on August 07, 2025. For the next earning release, we expect the company to report earnings of $0.03 per share, reflecting a year-over-year increase of 50.00%.
OptimizeRx Corp. has announced they will report their previous quarter earnings after the close of the market on August 07, 2025.
The Zacks Consensus Estimate for OptimizeRx Corp. (OPRX) for the quarter ending June 2025 is $0.03 a share. We expect OptimizeRx Corp. (OPRX) to report earnings in line with the consensus estimate of $0.03 per share
In the earnings report for the quarter ending in June 2024, OptimizeRx Corp. (OPRX) announced earnings of $0.02 per share versus the Zacks Consensus Estimate of $-0.07 per share, representing a surprise of -128.57%.